New Hep C Treatments Set to Overturn US Market, Says Study

New hep C treatments set to overturn US market, says study
The upcoming US market launches of two new hepatitis C virus (HCV) treatments will result in current triple- and dual-therapy regimens losing considerable market share, according to new research from BioTrends Research Group. Following the launches of … Read more on PharmaTimes

Nearest Rheumatologist 200 Miles Away for Some Patients
For rheumatology, specifically, he added, in areas with fewer dual-energy X-ray absorptiometry bone-density scanning machines, patients are less often screened for osteoporosis. Rheumatologists are also more likely than internists to prescribe disease … Read more on Medscape

Horse Racing Breakthrough – Guinea Pig To The Winner's Circle
The MPTS360 features breakthrough dual-nebulisation Technology through both Jet and Ultrasonic Nebulisation and studies with Australia's leading University confirmed the MPTS360 Nebuliser Technology is 500% more effective than any nebuliser available … Read more on PR Web (press release)